Edition:
United States

Veracyte Inc (VCYT.OQ)

VCYT.OQ on NASDAQ Stock Exchange Global Market

11.68USD
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
$11.68
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
70,096
52-wk High
$12.19
52-wk Low
$5.25

Chart for

About

Veracyte, Inc. is a genomic diagnostics company. The Company uses genomic technology to resolve diagnostic ambiguity. It targets diseases in which patients undergo invasive diagnostic procedures. Its products combine genomic technology, clinical science and machine learning. The Company commercializes over three genomic tests,... (more)

Overall

Beta: 1.74
Market Cap(Mil.): $460.68
Shares Outstanding(Mil.): 39.44
Dividend: --
Yield (%): --

Financials

  VCYT.OQ Industry Sector
P/E (TTM): -- 99.36 30.45
EPS (TTM): -0.91 -- --
ROI: -46.62 2.89 12.63
ROE: -83.95 1.65 14.82

BRIEF-Veracyte Files For Mixed Shelf Of Up To $125 Million

* VERACYTE INC FILES FOR MIXED SHELF OF UP TO $125 MILLION – SEC FILING Source text for Eikon: (http://bit.ly/2jlv3GH) Further company coverage:

May 01 2018

BRIEF-Veracyte Q1 Loss Per Share $0.27

* Q1 EARNINGS PER SHARE VIEW $-0.25 -- THOMSON REUTERS I/B/E/S

May 01 2018

BRIEF-Veracyte Announces Precision Medicine Collaboration With Loxo Oncology

* VERACYTE ANNOUNCES PRECISION MEDICINE COLLABORATION WITH LOXO ONCOLOGY

Apr 11 2018

BRIEF-Veracyte Inc Q4 Net Loss Per Common Share $0.24

* VERACYTE ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS, PROVIDES 2018 FINANCIAL OUTLOOK

Feb 27 2018

Earnings vs. Estimates